Ethinyl Estradiol and Lamotrigine Interaction

Drug interaction information between Ethinyl Estradiol and Lamotrigine.

Ethinyl Estradiol and Lamotrigine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Ethinyl Estradiol and Lamotrigine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Ethinyl Estradiol

Vaginal Contraceptive Ring

Drug B

Lamotrigine

Anticonvulsant

How They Interact

The birth control ring causes your body to process and remove the seizure medicine more quickly.

FDA Label Information

A significant decrease in the plasma concentrations of lamotrigine has been shown, likely due to induction of lamotrigine glucuronidation. This may reduce seizure control; therefore, dosage adjustments of lamotrigine may be necessary.

Frequently Asked Questions

What SPL severity band is on file for Ethinyl Estradiol/Etonogestrel + Lamotrigine?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Ethinyl Estradiol has 28 labeled pairs on file vs Lamotrigine's 24. In the minor band specifically: Ethinyl Estradiol has 27 (also Atorvastatin, Amoxicillin, Estradiol, Topiramate); Lamotrigine has 22 (also Valproate, Carbamazepine, Rifampin, Phenytoin).

What mechanism field is on file for Ethinyl Estradiol/Etonogestrel and Lamotrigine?

The birth control ring causes your body to process and remove the seizure medicine more quickly.

Ethinyl Estradiol's labeled portfolio outnumbers Lamotrigine

SPL source-record counts only. This page's band is minor · classes on file: Ethinyl Estradiol (Vaginal Contraceptive Ring); Lamotrigine (Anticonvulsant).

Ethinyl Estradiol

0 major · 1 moderate · 27 minor · 28 total

Lamotrigine

0 major · 2 moderate · 22 minor · 24 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.